Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 146 results found. Search for [ drug discovery ]

Results 1 to 21 of 146
PB Jayakumar
New Delhi, May 24, 2018
The US FDA recently gave green signal to market IDx-DR, a medical device to detect diabetic retinopathy, a disease in which high blood sugar damages blood vessels in the retina of eyes and leads to the vision loss.


PTI
May 7, 2018



PTI
March 26, 2018



Joe C Mathew
New Delhi, March 13, 2018
Close to 90 health activists, patient groups and individuals workingtowards the elimination of tuberculosis have called upon Prime MinisterNarendra Modi to make drug resistant TB (DR-TB) drugs affordable byensuring supply of generic drugs


Team BT
New Delhi, March 5, 2018
An exponential leap in processing power is around the corner, but will we use or abuse it?


Ajita Shashidhar
New Delhi, February 16, 2018
Zee Entertainment MD Punit Goenka has always been sceptical about offering content free. The home-grown media conglomerate earlier this week let out its digital strategy with the launch of Zee 5.


BusinessToday.in
New Delhi, February 19, 2018
Watch BusinessToday.in Editor Rajeev Dubey talk to Dr. Ben Feringa, Organic Chemist and Nobel Laureate on discovery of new drugs, Indian pharmaceutical companies penalised by FDA and the challenges faced by Indian pharma companies.


Gina Krishnan
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.


PTI
February 5, 2018



PTI
January 17, 2018



E Kumar Sharma
New Delhi, January 12, 2018
Many companies, with some leading players, are already coping with challenges around price erosion in generics, erosion of base business resulting from new competition and buyer consolidation in their biggest global market, the US.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


E Kumar Sharma
New Delhi, August 21, 2017
Certain pharma industry leaders point out that the draft of new pharmaceutical policy has been written in an amateurish manner.


Nevin John
Delhi, July 19, 2017
N. Chandrasekaran is doing his best to restore normalcy at the Tata Group after the acrimonious exit of Cyrus Mistry. But his problems are many.


Reuters
New Delhi, June 7, 2017
India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients.


Joe C Mathew
New Delhi, May 17, 2017
With presence in over 100 countries, India being one of its key geographies, the foundation aims to help find solutions to reduce extreme poverty and improve health.


Joe C Mathew
New Delhi, May 1, 2017
Apex think tank Niti Aayog has proposed a change in the manner the government identifies medicines that should be brought under price control.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


PTI
New Delhi, February 24, 2017
\"The company is in receipt of a 'Demand Notice' under the Section 156 of the Income Tax, 1961, demanding the payment by the company of a sum of Rs 32.87 crore for the assessment year 2013-14,\" it said.


E Kumar Sharma
New Delhi, January 18, 2017
Its misadventure in India had began in June 2008 with the acquisition of Ranbaxy in an over $4-billion deal (around Rs 20,000 crore then) with the promise of utilising Ranbaxy's resources to become a 'global pharma innovator'.


PAGES 1 OF 8  12345